OtusOphta Ltd.

Private

TampereHealthcare & Life Scienceshttps://www.otusophta.com/

Last Round

Grant

Oct 9, 2024

Company Overview

OtusOphta Ltd. is a biotechnology company developing a treatment for dry eye disease based on its RevEye technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

dry eye disease treatmentevaporative dry eye diseasetear film restorationDEDlipid-based therapeuticpreclinical biotechearly-stage biotechuniversity spinoutacademic spinoutophthalmology therapeuticclinical trialspharma licensingdrug discoverytear film lipid layer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OtusOphta Ltd. Comparables

Compare OtusOphta Ltd. with similar companies based on industry and business-model similarity.

OtusOphta Ltd. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
26 Therapeutics Inc.	79%
Stuart Therapeutics, Inc.	78%
Novaliq	73%

View all Comparables

OtusOphta Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 9, 2024
Seed	Oct 9, 2024

View all Funding Rounds

OtusOphta Ltd. Investors

Notable investors and investment history

OtusOphta Ltd. investors
Investor	Rounds
Helsinki University Funds	Seed
Business Finland	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 9, 2024
Seed round led by Helsinki University Funds.
Oct 9, 2024
Received grant funding from Business Finland.

View all signals

OtusOphta Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

OtusOphta Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OtusOphta Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTampere

Year Founded2024

Last FundingOct 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?